Clinical Research Directory
Browse clinical research sites, groups, and studies.
Hydrocortisone Versus Hydrocortisone Plus Fludrocortisone for the Treatment of Adrenal Insufficiency in Severe Sepsis
Sponsor: CAMC Health System
Summary
The purpose of this study is to determine if the combination of hydrocortisone plus fludrocortisone is more efficacious than hydrocortisone alone in treating adrenal insufficiency in severe sepsis.
Official title: A Blinded, Placebo Controlled Trial of Hydrocortisone Versus Hydrocortisone Plus Fludrocortisone for the Treatment of Adrenal Insufficiency in Severe Sepsis
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
0
Start Date
2006-09
Completion Date
2009-09
Last Updated
2026-08-31
Healthy Volunteers
No
Conditions
Interventions
Hydrocortisone
Hydrocortisone administered for the treatment of adrenal insufficiency in participants with severe sepsis.
Fludrocortisone
Fludrocortisone administered in combination with hydrocortisone for the treatment of adrenal insufficiency in participants with severe sepsis.